Last Updated on 2026 年 3 月 23 日 by 総合編集組
Thailand’s Cannabis Transformation 2024-2026: From Boom to Medical-Only Framework – Complete Guide for Tourists and Observers
Introduction: The Shift from Decriminalization to Strict Medical Regulation Thailand’s cannabis landscape underwent a dramatic evolution between 2024 and 2026. After decriminalizing cannabis in June 2022, becoming the first Asian nation to remove it from the narcotics list, the country witnessed explosive growth in retail outlets. By 2024, over 18,000 licensed shops operated nationwide, many in Bangkok, catering to both locals and international tourists seeking recreational access.
However, rising public health concerns—such as a 3.5-fold increase in cannabis poisoning cases, a 6.5-fold rise in addiction reports, and growing mental health issues—prompted a major policy reversal. In June 2025, the Ministry of Public Health reclassified cannabis flower as a “controlled herb,” mandating medical supervision for all purchases and effectively ending the recreational gray zone.
This regulatory whiplash, often termed “Regulatory Whiplash,” transformed the market from chaotic retail expansion to a tightly controlled medical ecosystem. By February 2026, the number of active licensed shops had fallen to around 11,136, with over 7,000 closures reported in 2025 alone due to failure to meet new compliance standards.
Market Statistics and Economic Dynamics The rapid contraction is evident in key figures:
- Nationwide licensed shops: Peaked at approximately 18,000+ in 2024; reached 18,433 by late 2025; dropped to 11,136 by February 2026.
- License expirations and renewals: In 2025, 8,636 licenses expired, but only 15.5% (about 1,339) were renewed under stricter rules.
- Closures: Cumulative over 7,300 shops shut down by early 2026, with projections of further reductions to 2,000–5,000 by 2027.
- Market valuation: Valued at $1.31 billion in 2024, slightly declined to around $12 billion in 2025 under restrictions, and forecasted at $11.5 billion in 2026. Long-term outlook remains positive, with estimates projecting $71–96 billion by 2030, driven by a compound annual growth rate (CAGR) of about 33%.
- Medical use share: Rose from 53.9% in 2024 to dominating the market in 2026, expected to exceed 85%.
Despite fewer physical stores, the industry is shifting toward premium, high-margin medical products, CBD derivatives, and vertically integrated operations. Larger operators with capital for GACP-certified supply chains and on-site medical staff are surviving and consolidating market share.
The PT33 Prescription System: Core Mechanism in 2026 The cornerstone of Thailand’s current framework is the PT33 prescription form. All cannabis purchases, including flower, require this document issued by a licensed Thai healthcare practitioner. Key requirements include:
- Eligible prescribers: Licensed medical doctors, Thai traditional medicine practitioners, applied Thai traditional medicine doctors, Chinese medicine practitioners, dentists, pharmacists, and certified folk healers.
- Validity and limits: Maximum 30-day duration, single-use only, no automatic refills.
- Linked conditions: Must relate to approved medical indications such as chronic pain, insomnia, migraines, Parkinson’s disease, or nausea from cancer treatment.
- Record-keeping: Clinics and dispensaries must retain patient diagnosis proof, prescription copies, and purchase records for at least one year for inspections.
For tourists, the process is standardized:
- Visit a licensed clinic or dispensary with medical services (common in Bangkok’s Sukhumvit, Asok, or Silom areas).
- Undergo consultation (fees typically 100–500 THB).
- Present passport for ID verification and registration.
- Receive PT33 form if approved, then purchase products.
Many dispensaries integrate the consultation into their systems via tablets, making it efficient. Foreign prescriptions or medical cards hold no validity in Thailand.
Risks and Common Pitfalls for Tourists Violations carry serious consequences:
- Public consumption prohibited (streets, parks, beaches); fines up to 25,000 THB or public nuisance charges.
- Carrying without valid PT33 may result in fines or arrest for controlled substance possession.
- Exporting any cannabis product is strictly forbidden, with airport arrests reported.
- Street vendors in areas like Khao San Road often sell unregulated products; buyers risk penalties during police checks.
- Police patrols have increased in nightlife zones (Nana, Soi Cowboy), frequently requesting proof if cannabis odor is detected.
Popular Compliant Brands and User Experiences Community feedback (e.g., Reddit, travel forums) highlights several brands adapting successfully:
- Cloud Nine (Surawong and Asok): Praised for seamless on-site doctor consultations and clear strain explanations.
- Kush House: Partners with labs for tested products; strict QR-code registration and detailed CBD/THC ratio guidance.
- Fat Buds: Affordable consultations (100–120 THB) and compliant lounge areas for safe consumption.
- The Dispensary (Sukhumvit flagship): High-end aesthetic with complete terpene profiles and professional medical guidance.
Geographic Differences in Bangkok
- Sukhumvit area: Evolved into medical-focused hubs with modern interiors, strict zoning, and preference for in-store or private use.
- Khao San Road: Retains a more casual vibe but faces frequent enforcement; street sales persist but carry high risks.
Supply Chain Reforms: GACP Certification All medical-grade cannabis must come from GACP-certified Thai farms (no imports). This eliminates low-quality outdoor or black-market sources. Indoor cultivation rose to over 54% by 2024 and continues growing, enhancing traceability and quality assurance. Consumers can request COA reports and certification numbers.
Social and Political Context The 2026 election saw major parties align on restricting cannabis to medical use. Public health costs (emergency visits, addiction treatment) outweighed tax revenue from the earlier boom, especially from tourist-related incidents (over 90 monthly overdose cases in hotspots).
Future Outlook Thailand aims to become an Asian medical cannabis hub, emphasizing export-oriented R&D and pharmaceutical standards. Retail entertainment era has ended; opportunities now lie in upstream cultivation, compliance tech, and research.
Conclusion Thailand’s cannabis scene in 2026 is more professional, safer, and medically oriented. While access requires effort, compliant pathways exist for those who follow PT33 rules. Travelers should prioritize licensed venues, carry prescriptions, and avoid public use to ensure a positive experience.
